NCT04022200 (DCB-denovo) is a clinical trial of Paclitaxel DCB in Coronary Disease, sponsored by Beijing Hospital.

Who is sponsoring NCT04022200?

NCT04022200 is sponsored by Beijing Hospital.

What drugs are being tested in NCT04022200?

Interventions in NCT04022200: Paclitaxel DCB.

What condition does NCT04022200 study?

NCT04022200 studies Coronary Disease.

Is NCT04022200 still recruiting?

NCT04022200 is currently status unknown. Last updated 22 March 2022.

Last reviewed 2022-03-22 · How we verify

NCT04022200: DCB-denovo

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Angioplasty With Paclitaxel-coated Balloon Only Strategy for Coronary de Novo Lesions

Status unknown Last updated 22 March 2022

What this trial tests

trial testing Paclitaxel DCB in Coronary Disease in 300 participants. Status unknown.

Timeline

1 August 2019

Primary endpoint
31 January 2023

31 July 2023

Quick facts

Lead sponsor	Beijing Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 August 2019
Primary completion	31 January 2023
Estimated completion	31 July 2023
Sites	1 location across China

Drugs / interventions tested

Paclitaxel DCB

Conditions studied

Coronary Disease — all drugs for Coronary Disease →

Sponsor

Beijing Hospital

Who can join

18 and older, any sex, with Coronary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Drug-coating balloon (DCB) is a new interventional device for treatment of obstructive coronary artery disease (CAD). There is limited data on the long term efficacy and safety of DCB-only strategy for coronary de novo lesions in Asian patients. We therefore carry out this registry study to evaluated the clinical outcomes of paclitaxel DCB in Chinese patients in a real world medical practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Paclitaxel DCB

Trials testing the same drug.

NCT05450042 — Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation · NA · unknown
NCT03223974 — Clinical Trial on Safety and Efficacy of Drug-coated Balloon in Treatment of Coronary Bifurcation Lesions · NA · completed

Other recruiting trials for Coronary Disease

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT06736899 — Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions · NA · recruiting
NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
NCT07094737 — The Italian Alliance for Cardiovascular Rehabilitation and Prevention (ITACARE-P) Registry: An Observational Study on Ca · recruiting
NCT06701968 — Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease · NA · recruiting

Other Beijing Hospital trials

Trials by the same sponsor.

NCT07523724 — Screening and Management of Adults With Asthma and Allergic Diseases · NA · not yet recruiting
NCT07398430 — Metabolic Characteristics and Prognostic Model of Acute Coronary Syndrome Complicated With Obstructive Sleep Apnea · not yet recruiting
NCT07295665 — External Validation of Ischemia and Hemorrhage Risk Models in Patients With Coronary Heart Disease · not yet recruiting
NCT07143851 — Multi-modal Intelligent Diagnosis System for Multiple Ophthalmic Diseases · not yet recruiting
NCT06955819 — GUTPROH: Probiotic-Herbal Formula for Self-Reported Constipation in Community Adults · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04022200 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beijing Hospital
Last refreshed: 22 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04022200.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing